Skip to main content

Georgia-Based Hamilton Health Care System First in U.S. to Use New Baxter Technology in the ICU

Press Release
  • Baxter’s innovative PrisMax system for managing acute kidney injury (AKI) is now FDA cleared and available in the U.S.

  • Hamilton is the first institution in the U.S. to use this system to treat critically ill patients

PDF

DALTON, Ga. and DEERFIELD, Ill. - August 13, 2019

Hamilton Health Care System, a top 10% national hospital provider in overall health care according to CareChex® medical quality ratings, and Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced that Hamilton is the first health system in the U.S. to use Baxter’s new PrisMax system. Designed with real-world input from more than 650 healthcare providers around the world, Baxter’s PrisMax system offers innovative technology used in the intensive care unit (ICU) to treat patients with acute kidney injury (AKI), which can be life-threatening.

Hamilton Health Care System chose the PrisMax system to further enhance its critical care services, including the ability to treat area patients who develop AKI. PrisMax includes new digital health features that allow hospitals to connect the system to electronic medical record (EMR) platforms. This enables straightforward integration of information from PrisMax to the EMR, allowing ICU nurses to spend less time manually documenting treatment data, while reducing the risk of transcription errors.

“Hamilton is excited to be the first U.S. hospital to adopt this innovative technology in continuous renal replacement therapy,” said Elwyn Clark, D.O., director, Critical Care Medicine at Hamilton. “We value our partnership with the Baxter team for training, education, and continuous improvement of our therapy offerings in the ICU. Baxter’s new PrisMax device should reduce workload on our nurses and allow them to spend more time on patient care.”

“I am impressed by the collaborative and close coordination of care between intensivists and nephrologists at Hamilton,” said Brian Tufts, Baxter’s U.S. lead for Acute Therapies. “The Hamilton team is truly bringing world-class care to a community setting in northern Georgia and Baxter is proud to support their leading patient care approach with our products and services.”

About Hamilton Health

Hamilton Health Care System is a not-for-profit, fully united system of care serving the northwest Georgia region. The Dalton-based flagship of the system, Hamilton Medical Center, is a 282-bed regional acute-care hospital that offers major medical, surgical and diagnostic services, including award-winning, accredited stroke and chest pain centers.

Known for its advanced care and personalized service, Hamilton Health Care System offers innovative treatment options in state-of-the-art facilities while maintaining a compassionate, friendly and tranquil healing environment.

For more information, please visit www.hamiltonhealth.com.

About Baxter

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on TwitterLinkedIn and Facebook.

PrisMax is Rx Only: For safe and proper use of the devices mentioned herein, refer to the complete instructions in the Operator's Manual.

This release includes forward-looking statements concerning PrisMax, including potential benefits associated with its use. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.

Baxter and PrisMax are registered trademarks of Baxter International Inc.

Related Headlines